Literature DB >> 20799856

MicroRNA-1 regulates smooth muscle cell differentiation by repressing Kruppel-like factor 4.

Changqing Xie1, Huarong Huang, Xuan Sun, Yanhong Guo, Milton Hamblin, Raquel P Ritchie, Minerva T Garcia-Barrio, Jifeng Zhang, Y Eugene Chen.   

Abstract

The role of microRNA-1 (miR-1) has been studied in cardiac and skeletal muscle differentiation. However, it remains unexplored in vascular smooth muscle cells (SMCs) differentiation. The aim of this study was to uncover novel targets of and shed light on the function of miR-1 in the context of embryonic stem cell (ESC) differentiation of SMCs in vitro. miR-1 expression is steadily increased during differentiation of mouse ESC to SMCs. Loss-of-function approaches using miR-1 inhibitors uncovered that miR-1 is required for SMC lineage differentiation in ESC-derived SMC cultures, as evidenced by downregulation of SMC-specific markers and decrease of derived SMC population. In addition, bioinformatics analysis unveiled a miR-1 binding site on the Kruppel-like factor 4 (KLF4) 3' untranslated region (3'UTR), in a region that is highly conserved across species. Consistently, miR-1 mimic reduced KLF4 3'UTR luciferase activity, which can be rescued by mutating the miR-1 binding site on the KLF4 3'UTR in the reporter construct. Additionally, repression of the miR-1 expression by miR-1 inhibitor can reverse KLF4 downregulation during ESC-SMC differentiation, which subsequently inhibits SMC differentiation. We conclude that miR-1 plays a critical role in the determination of SMC fate during retinoid acid-induced ESC/SMC differentiation, which may indicate that miR-1 has a role to promote SMC differentiation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20799856      PMCID: PMC3128754          DOI: 10.1089/scd.2010.0283

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  34 in total

1.  Expression profiling of nuclear receptors in human and mouse embryonic stem cells.

Authors:  Chang-Qing Xie; Yangsik Jeong; Mingui Fu; Angie L Bookout; Minerva T Garcia-Barrio; Tingwan Sun; Bong-Hyun Kim; Yang Xie; Sierra Root; Jifeng Zhang; Ren-He Xu; Y Eugene Chen; David J Mangelsdorf
Journal:  Mol Endocrinol       Date:  2009-02-05

2.  A comparison of murine smooth muscle cells generated from embryonic versus induced pluripotent stem cells.

Authors:  Chang-Qing Xie; Huarong Huang; Sheng Wei; Long-Sheng Song; Jifeng Zhang; Raquel P Ritchie; Liangbiao Chen; Ming Zhang; Y Eugene Chen
Journal:  Stem Cells Dev       Date:  2009-06       Impact factor: 3.272

Review 3.  MicroRNA control of muscle development and disease.

Authors:  Andrew H Williams; Ning Liu; Eva van Rooij; Eric N Olson
Journal:  Curr Opin Cell Biol       Date:  2009-03-09       Impact factor: 8.382

4.  Induction of microRNA-221 by platelet-derived growth factor signaling is critical for modulation of vascular smooth muscle phenotype.

Authors:  Brandi N Davis; Aaron C Hilyard; Peter H Nguyen; Giorgio Lagna; Akiko Hata
Journal:  J Biol Chem       Date:  2008-12-15       Impact factor: 5.157

5.  PIAS1 mediates TGFbeta-induced SM alpha-actin gene expression through inhibition of KLF4 function-expression by protein sumoylation.

Authors:  Keiko Kawai-Kowase; Takayuki Ohshima; Hiroki Matsui; Toru Tanaka; Takehisa Shimizu; Tatsuya Iso; Masashi Arai; Gary K Owens; Masahiko Kurabayashi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-10-16       Impact factor: 8.311

6.  A necessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia.

Authors:  Xiaojun Liu; Yunhui Cheng; Shuo Zhang; Ying Lin; Jian Yang; Chunxiang Zhang
Journal:  Circ Res       Date:  2009-01-15       Impact factor: 17.367

7.  Involvement of MicroRNAs in hydrogen peroxide-mediated gene regulation and cellular injury response in vascular smooth muscle cells.

Authors:  Ying Lin; Xiaojun Liu; Yunhui Cheng; Jian Yang; Yuqing Huo; Chunxiang Zhang
Journal:  J Biol Chem       Date:  2009-01-21       Impact factor: 5.157

8.  MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation.

Authors:  Yunhui Cheng; Xiaojun Liu; Jian Yang; Ying Lin; Da-Zhong Xu; Qi Lu; Edwin A Deitch; Yuqing Huo; Ellise S Delphin; Chunxiang Zhang
Journal:  Circ Res       Date:  2009-06-18       Impact factor: 17.367

9.  Sp1-dependent activation of KLF4 is required for PDGF-BB-induced phenotypic modulation of smooth muscle.

Authors:  Rebecca A Deaton; Qiong Gan; Gary K Owens
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-01-23       Impact factor: 4.733

10.  miR-145 and miR-143 regulate smooth muscle cell fate and plasticity.

Authors:  Kimberly R Cordes; Neil T Sheehy; Mark P White; Emily C Berry; Sarah U Morton; Alecia N Muth; Ting-Hein Lee; Joseph M Miano; Kathryn N Ivey; Deepak Srivastava
Journal:  Nature       Date:  2009-07-05       Impact factor: 49.962

View more
  62 in total

1.  A KLF4-miRNA-206 autoregulatory feedback loop can promote or inhibit protein translation depending upon cell context.

Authors:  Chen-Chung Lin; Ling-Zhi Liu; Joseph B Addison; William F Wonderlin; Alexey V Ivanov; J Michael Ruppert
Journal:  Mol Cell Biol       Date:  2011-04-25       Impact factor: 4.272

Review 2.  MicroRNA regulation of smooth muscle gene expression and phenotype.

Authors:  Hara Kang; Akiko Hata
Journal:  Curr Opin Hematol       Date:  2012-05       Impact factor: 3.284

Review 3.  An overview of potential molecular mechanisms involved in VSMC phenotypic modulation.

Authors:  Ming-Jie Zhang; Yi Zhou; Lei Chen; Yan-Qin Wang; Xu Wang; Yan Pi; Chang-Yue Gao; Jing-Cheng Li; Li-Li Zhang
Journal:  Histochem Cell Biol       Date:  2015-12-26       Impact factor: 4.304

Review 4.  Bone marrow mesenchymal stem cells for post-myocardial infarction cardiac repair: microRNAs as novel regulators.

Authors:  Zhuzhi Wen; Shaoxin Zheng; Changqing Zhou; Woliang Yuan; Jingfeng Wang; Tong Wang
Journal:  J Cell Mol Med       Date:  2012-04       Impact factor: 5.310

Review 5.  MicroRNAs as novel regulators of stem cell fate.

Authors:  Eunhyun Choi; Eunmi Choi; Ki-Chul Hwang
Journal:  World J Stem Cells       Date:  2013-10-26       Impact factor: 5.326

Review 6.  Micromanaging vascular smooth muscle cell differentiation and phenotypic modulation.

Authors:  Brandi N Davis-Dusenbery; Connie Wu; Akiko Hata
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-11       Impact factor: 8.311

Review 7.  Non-coding RNAs: key regulators of smooth muscle cell fate in vascular disease.

Authors:  Nicholas J Leeper; Lars Maegdefessel
Journal:  Cardiovasc Res       Date:  2018-03-15       Impact factor: 10.787

Review 8.  Mechanisms and therapeutic potential of microRNAs in hypertension.

Authors:  Lijun Shi; Jingwen Liao; Bailin Liu; Fanxing Zeng; Lubo Zhang
Journal:  Drug Discov Today       Date:  2015-05-21       Impact factor: 7.851

Review 9.  Noncoding RNAs in smooth muscle cell homeostasis: implications in phenotypic switch and vascular disorders.

Authors:  N Coll-Bonfill; B de la Cruz-Thea; M V Pisano; M M Musri
Journal:  Pflugers Arch       Date:  2016-04-25       Impact factor: 3.657

10.  Vascular smooth muscle cell contractile protein expression is increased through protein kinase G-dependent and -independent pathways by glucose-6-phosphate dehydrogenase inhibition and deficiency.

Authors:  Sukrutha Chettimada; Sachindra Raj Joshi; Vidhi Dhagia; Alessandro Aiezza; Thomas M Lincoln; Rakhee Gupte; Joseph M Miano; Sachin A Gupte
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-08-12       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.